Lipid CME

IMPROVE-IT: Ezetimibe Added to Statin Therapy After Acute Coronary Syndromes – A Critical Appraisal

Author(s)/Faculty: Christopher P. Cannon, MD
Release Date: 2/24/2016Expiration Date: 1/11/2019
Credit Type: CMENumber of Credits: 0.25
Content Type: ArticleProvider:
Dr. Cannon assesses the impact of the IMPROVE-IT clinical trial and how its results relate to treating patients with dyslipidemia at high risk for cardiovascular events.